Pharmaceutical Innovation and Access to Medicines

pharmaceutical innovation | Fraser Institute

Drug developers are more likely to invest in research and development if prices for their medicines are high. Tags: new prescription drugs, access to new ...

Time for new pharmaceutical-innovation models

Tools for Access to Medicines. Tools to help governments and others looking to increase access to medicines by using flexibilities in ...

Promoting access to medical technologies and innovation ...

DiMasi, J.A., Hansen, R.W. and Grabowski, H.G. (2003), “The Price of Innovation: New Estimates of Drug Development Costs”, Journal of Health Economics 22(2): ...

Strengthening Pharmaceutical Innovation in Africa

Innovation for health/ Technology transfer/Pharmaceutical innovation/ Pharmaceutical ... access to medicines and pharmaceutical innovation for our future. Dr ...

Can affordability and innovation coexist for medicines? - The BMJ

A worrying gap exists between the promise of medical innovation and affordable access for all. When medicines are found to be truly ...

Regulation and Innovation: Role of Regulatory Science in ...

3 Interestingly, patient-focused drug development is a renewed priority for the FDA under the auspices of the 21st Century Cures legislation, ...

Program: Drug Development - PATH

Drug Innovation and Access Initiative ... We advance the most promising medicines for a range of urgent global health challenges and ensure that treatment is ...

Ensuring Access to Innovative Medicines: Big Pharma's Role

Novartis program examples are the Glivec International Patient Assistance Program (GIPAP) / Novartis Oncology Access (NOA) / Novartis Access ...

Improving access to medicines in the UK

The UK is a world leader in pharmaceutical research and development, and it is vital that NHS patients are able to access the latest treatments as fast as ...

Access to medicines and incentives for innovation - CEPAL

The analysis focuses on the patent and data-related intellectual property protection provisions of the TPPA, specifically regarding pharmaceutical (small- ...

Innovative medicinal products | Italian Medicines Agency - AIFA

AIFA has provided that the assessment of innovation must be performed through a single model for all medicines, also allowing, if necessary, the use of ...

Governing pharmaceutical innovations in Africa: Inclusive models for ...

The implications for African economies in the area of generic drug production and global health outcomes are vast given the potential to increase access to ...

Expanded Access & Compassionate Use - Clinical Trials - Pfizer

Such individual use of an investigational drug pre-approval is often called “expanded access” or “compassionate use” but may go by other names.

Innovation–Innovation Tradeoffs in Drug Pricing - ACP Journals

To encourage greater affordability and access, policymakers, academics, and other stakeholders have offered proposals that would reduce payment to ...

Increasing Pharmaceutical Innovation, Ensuring Health Coverage ...

With improved economic prosperity, social mobility, [a] growing segment of prescription drugs, and increased access to advanced health care, we ...

Research and Development in the Pharmaceutical Industry

CBO also examines factors that determine how much drug companies spend on R&D: expected global revenues from a new drug; cost to develop a new ...

Pharmaceutical innovation continues to drive improvements in ...

Over the past 15 years, pharmaceutical innovation, coupled with lower prices and improved access to essential medicines, ...

Using Value-Agnostic Incentives to Promote Pharmaceutical ...

Instead, this Note proposes “value-agnostic” programs, which indirectly influence innovation while leaving original disease- and drug-level ...

Pharma trends 2024: Shaping the future landscape | ZS

Building resilience through scientific and portfolio innovation · New drugs will create a revolution for obesity treatment. · Disease-modifying ...

Trade and Access to Medicines in the COVID-19 Era: GDP Center ...

... innovation in pharmaceuticals. The most important and long-standing of such standards is China's data exclusivity law, which keeps generic ...